A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocolElizaveta Gribaleva, Carsten Flohr, Abaigeal Jackson et al.|Skin Health and Disease|2025Cited by 1
Crispri Essentiality Screen Reveals the Essential Enhancers and Oncogenes Comprising the “Regulome” of the Notch-Collaborating Transcription Factor ETS1 in Human T-ALLKarena Lin, Mark Y. Chiang, Annie Wang et al.|Blood|2024Cited by 0